文献速递白血病

谷氨酸脱氢酶1:抑制急性髓系白血病进展的新代谢靶点

Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression.
PubMed 文献 · Br J Haematol · 2023-05-25

该研究报道谷氨酸脱氢酶1(GDH1)在急性髓系白血病(AML)中高表达,且高GDH1为AML队列中的独立不良预后因素之一。体外和体内实验证实白血病细胞依赖GDH1,靶向GDH1可清除原始细胞并延缓AML进展。机制上,GDH1抑制通过下调SLC1A5抑制谷氨酰胺摄取,并抑制SLC3A2、阻断胱氨酸-谷氨酸逆向转运系统Xc-,以谷胱甘肽耗竭方式触发铁死亡,与阿糖胞苷合成致死。

要点

  • GDH1在AML中高表达,高GDH1是AML队列独立不良预后因素之一。
  • 靶向GDH1可清除原始细胞并延缓AML进展,体外和体内实验均证实白血病细胞依赖GDH1。
  • GDH1抑制以谷胱甘肽耗竭方式触发铁死亡,与阿糖胞苷合成致死。

核心结论

  • 抑制GDH1通过谷胱甘肽耗竭方式在AML细胞中触发铁死亡,与阿糖胞苷合成致死,为清除恶性AML细胞提供了可操作的治療机会和独特靶点。

研究设计与样本

  • 研究在AML队列中分析GDH1表达的预后意义,并在体外和体内实验中验证白血病细胞对GDH1的依赖。

主要发现

  • GDH1在AML中高表达,高GDH1是AML队列中的独立负性预后因素之一。
  • 白血病细胞而非其髓系对应细胞在很大程度上依赖谷氨酰胺。
  • 高GDH1促进细胞增殖并缩短白血病小鼠的生存时间。
  • 靶向GDH1清除原始细胞并延缓AML进展。
  • GDH1敲低通过下调SLC1A5抑制谷氨酰胺摄取,GDH1失活还抑制SLC3A2并阻断胱氨酸-谷氨酸逆向转运系统Xc-。

关键数值与推荐

  • 胱氨酸和谷氨酰胺减少破坏了谷胱甘肽(GSH)合成,导致以GSH为辅因子的谷胱甘肽过氧化物酶4(GPX4)功能障碍。
  • GDH1抑制以GSH耗竭方式触发AML细胞铁死亡,并与化疗药物阿糖胞苷合成致死。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glutamine metabolic reprogramming in acute myeloid leukaemia (AML) cells contributes to the decreased sensitivity to antileukemic drugs. Leukaemic cells, but not their myeloid counterparts, largely depend on glutamine. Glutamate dehydrogenase 1 (GDH1) is a regulation enzyme in glutaminolysis. However, its role in AML remains unknown. Here, we reported that GDH1 was highly expressed in AML: high GDH1 was one of the independent negative prognostic factors in AML cohort. The dependence of leukaemic cells on GDH1 was proved both in vitro and in vivo. High GDH1 promoted cell proliferation and reduced survival time of leukaemic mice. Targeting GDH1 eliminated the blast cells and delayed AML progression. Mechanistically, GDH1 knockdown inhibited glutamine uptake by downregulating SLC1A5. Moreover, GDH1 invalidation also inhibited SLC3A2 and abrogated the cystine-glutamate antiporter system Xc- . The reduced cystine and glutamine disrupted the synthesis of glutathione (GSH) and led to the dysfunction of glutathione peroxidase-4 (GPX4), which maintains the lipid peroxidation homeostasis by using GSH as a co-factor. Collectively, triggering ferroptosis in AML cells in a GSH depletion manner, GDH1 inhibition was synthetically lethal with the chemotherapy drug cytarabine. Ferroptosis induced by inhibiting GDH1 provides an actionable therapeutic opportunity and a unique target for synthetic lethality to facilitate the elimination of malignant AML cells.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Ma Z, Ye W, Wang J, et al. Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression. Br J Haematol. 2023. PMID: 37231991. doi:10.1111/bjh.18884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。